Eiropas Savienība - zviedru - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - cd19-directed genetically modified autologous cell-based product consisting of purified cd8+ t-cells (cd8+ cells), cd19-directed genetically modified autologous cell-based product consisting of purified cd4+ t cells (cd4+ cells) - lymphoma, large b-cell, diffuse; lymphoma, follicular; mediastinal neoplasms - antineoplastiska medel - breyanzi is indicated for the treatment of adult patients with diffuse large b-cell lymphoma (dlbcl), high grade b-cell lymphoma (hgbcl), primary mediastinal large b-cell lymphoma (pmbcl) and follicular lymphoma grade 3b (fl3b), who relapsed within 12 months from completion of, or are refractory to, first-line chemoimmunotherapy.

Eiropas Savienība - zviedru - EMA (European Medicines Agency)

pierre fabre medicament - tabelecleucel - lymphoproliferative disorders - ebvallo is indicated as monotherapy for treatment of adult and paediatric patients 2 years of age and older with relapsed or refractory epstein-barr virus positive post-transplant lymphoproliferative disease (ebv+ ptld) who have received at least one prior therapy. for solid organ transplant patients, prior therapy includes chemotherapy unless chemotherapy is inappropriate.

Zviedrija - zviedru - Läkemedelsverket (Medical Products Agency)

hetero europe s.l. - levetiracetam - filmdragerad tablett - 1000 mg - levetiracetam 1000 mg aktiv substans - levetiracetam

Zviedrija - zviedru - Läkemedelsverket (Medical Products Agency)

hetero europe s.l. - levetiracetam - filmdragerad tablett - 250 mg - levetiracetam 250 mg aktiv substans - levetiracetam

Zviedrija - zviedru - Läkemedelsverket (Medical Products Agency)

hetero europe s.l. - levetiracetam - filmdragerad tablett - 500 mg - levetiracetam 500 mg aktiv substans - levetiracetam

Zviedrija - zviedru - Läkemedelsverket (Medical Products Agency)

hetero europe s.l. - levetiracetam - filmdragerad tablett - 750 mg - levetiracetam 750 mg aktiv substans; para-orange aluminiumlack hjälpämne - levetiracetam

Zviedrija - zviedru - Läkemedelsverket (Medical Products Agency)

h. lundbeck a/s - escitalopram - munsönderfallande tablett - 10 mg - mannitol hjälpämne; escitalopram 10 mg aktiv substans - escitalopram

Zviedrija - zviedru - Läkemedelsverket (Medical Products Agency)

h. lundbeck a/s - escitalopram - munsönderfallande tablett - 20 mg - mannitol hjälpämne; escitalopram 20 mg aktiv substans - escitalopram

Zviedrija - zviedru - Läkemedelsverket (Medical Products Agency)

h. lundbeck a/s - escitalopram - munsönderfallande tablett - 10 mg - mannitol hjälpämne; escitalopram 10 mg aktiv substans - escitalopram

Zviedrija - zviedru - Läkemedelsverket (Medical Products Agency)

h. lundbeck a/s - escitalopram - munsönderfallande tablett - 20 mg - escitalopram 20 mg aktiv substans; mannitol hjälpämne - escitalopram